HK1258957A1 - Treatment of metastatic stage prostate cancer with degarelix - Google Patents

Treatment of metastatic stage prostate cancer with degarelix

Info

Publication number
HK1258957A1
HK1258957A1 HK19101439.6A HK19101439A HK1258957A1 HK 1258957 A1 HK1258957 A1 HK 1258957A1 HK 19101439 A HK19101439 A HK 19101439A HK 1258957 A1 HK1258957 A1 HK 1258957A1
Authority
HK
Hong Kong
Prior art keywords
degarelix
treatment
prostate cancer
stage prostate
metastatic stage
Prior art date
Application number
HK19101439.6A
Other languages
Chinese (zh)
Inventor
Jens-Kristian Slott Jensen
Der Meulen Egbert A Van
Per Cantor
Bo-Eric Persson
Tine Kold Olesen
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HK1258957A1 publication Critical patent/HK1258957A1/en

Links

HK19101439.6A 2008-02-11 2019-01-28 Treatment of metastatic stage prostate cancer with degarelix HK1258957A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2774108P 2008-02-11 2008-02-11
EP08250703 2008-02-29

Publications (1)

Publication Number Publication Date
HK1258957A1 true HK1258957A1 (en) 2019-11-22

Family

ID=69095472

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19101439.6A HK1258957A1 (en) 2008-02-11 2019-01-28 Treatment of metastatic stage prostate cancer with degarelix

Country Status (3)

Country Link
JP (1) JP7104003B2 (en)
HK (1) HK1258957A1 (en)
JO (1) JO3525B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20090061B1 (en) * 2008-02-11 2021-08-17 Ferring Int Center Sa METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

Also Published As

Publication number Publication date
JP7104003B2 (en) 2022-07-20
JP2019218360A (en) 2019-12-26
JO3525B1 (en) 2020-07-05

Similar Documents

Publication Publication Date Title
HK1145011A1 (en) Treatment of metastatic stage prostate cancer with degarelix
ZA201008140B (en) Treatment of metastatic tumors
EP2461814A4 (en) Treatment of prostate cancer
IL215108A0 (en) Amatoxin-armed target-binding moieties for the treatment of cancer
HK1175476A1 (en) Cancer treatment
IL218575A0 (en) Treatment of cancer
IL217291A0 (en) Exosome based treatment of cancer
EP2310006A4 (en) Treating cancer
EP2197533A4 (en) Prostate cancer ablation
ZA201107879B (en) Composition for the treatment of prostate cancer
GB0804496D0 (en) Treating cancer
PL388252A1 (en) Combination therapy of colorectal cancer
GB0916686D0 (en) Treatment of cancer
HK1258957A1 (en) Treatment of metastatic stage prostate cancer with degarelix
GB0809046D0 (en) Cancer treatment
GB0822016D0 (en) Treatment of metastatic cancer
GB0705205D0 (en) Treatment of metastatic cancer
AU2008906236A0 (en) Prostate Cancer Treatment Rectal Probe
GB0822018D0 (en) Prevention of metastatic cancer
GB0612369D0 (en) Treatment of metastatic cancer
GB0712513D0 (en) Treatment of cancer
GB0921757D0 (en) Treatment of cancer
GB0809730D0 (en) Improvements in the chemotherapy of cancer
GB0818566D0 (en) Improvements in the chemotherapy of cancer
GB0813361D0 (en) Treatment of cancer fatigue